We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-4.3%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.81B
AUM Growth
+$135M
Cap. Flow
+$468M
Cap. Flow %
8.05%
Top 10 Hldgs %
22.38%
Holding
604
New
28
Increased
196
Reduced
108
Closed
52

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$52.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$45.1M
3
PCAR icon
PACCAR
PCAR
+$42.3M
4
KLAC icon
KLA
KLAC
+$37.4M
5
AMZN icon
Amazon
AMZN
+$23.1M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$51.7M
2
ABT icon
Abbott
ABT
+$30.9M
3
PFE icon
Pfizer
PFE
+$29.6M
4
VSAT icon
Viasat
VSAT
+$18M
5
QCOM icon
Qualcomm
QCOM
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Healthcare 18.76%
3 Financials 9.65%
4 Consumer Discretionary 9.57%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
476
Best Buy
BBY
$17.3B
$194K ﹤0.01%
2,789
-3,751
-57% -$290K
ZNTL icon
477
Zentalis Pharmaceuticals
ZNTL
$300M
$192K ﹤0.01%
9,800
MORF
478
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$191K ﹤0.01%
8,500
RLAY icon
479
Relay Therapeutics
RLAY
$4.31B
$190K ﹤0.01%
23,100
SIGI icon
480
Selective Insurance
SIGI
$5.73B
$188K ﹤0.01%
1,800
KROS icon
481
Keros Therapeutics
KROS
$221M
$186K ﹤0.01%
5,700
FAF icon
482
First American
FAF
$7.58B
$182K ﹤0.01%
3,200
BRK.B icon
483
Berkshire Hathaway Class B
BRK.B
$1.13T
$173K ﹤0.01%
495
SU icon
484
Suncor Energy
SU
$70.3B
$166K ﹤0.01%
4,800
PVH icon
485
PVH
PVH
$4.04B
$166K ﹤0.01%
2,202
+65
+3% +$5.38K
SANA icon
486
Sana Biotechnology
SANA
$980M
$160K ﹤0.01%
40,000
INBX
487
DELISTED
Inhibrx, Inc. Common Stock
INBX
$158K ﹤0.01%
8,700
WRB icon
488
W.R. Berkley
WRB
$26.6B
$156K ﹤0.01%
3,600
IOVA icon
489
Iovance Biotherapeutics
IOVA
$2.83B
$155K ﹤0.01%
34,000
VERV
490
DELISTED
Verve Therapeutics
VERV
$146K ﹤0.01%
11,300
SIG icon
491
Signet Jewelers
SIG
$3.76B
$129K ﹤0.01%
1,793
-49,116
-96% -$3.64M
ALEC icon
492
Alector
ALEC
$198M
$127K ﹤0.01%
19,000
TDOC icon
493
Teladoc Health
TDOC
$1.3B
$123K ﹤0.01%
6,649
AVXL icon
494
Anavex Life Sciences
AVXL
$310M
$121K ﹤0.01%
18,000
AEM icon
495
Agnico Eagle Mines
AEM
$90.5B
$114K ﹤0.01%
2,500
-59,589
-96% -$2.92M
IXJ icon
496
iShares Global Healthcare ETF
IXJ
$4.18B
$111K ﹤0.01%
1,350
-100
-7% -$8.48K
ALLO icon
497
Allogene Therapeutics
ALLO
$694M
$107K ﹤0.01%
31,400
EDIT icon
498
Editas Medicine
EDIT
$442M
$104K ﹤0.01%
15,000
KURA icon
499
Kura Oncology
KURA
$850M
$96.5K ﹤0.01%
11,000
FNF icon
500
Fidelity National Financial
FNF
$13.5B
$90.9K ﹤0.01%
2,200

Similar funds

Erste Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Erste Asset Management held 604 positions worth $5.81B, up 2.4% from $5.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $468M of net new capital in Q3 2023, opening 28 new positions and adding to 196 existing holdings. Its largest new stake was Constellation Brands: 50,120 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marriott International, an estimated $51.7M trimmed.

  • Erste Asset Management's largest Q3 2023 buy was Constellation Brands: 50,120 shares worth $12.6M.
  • Erste Asset Management added most to Visa in Q3 2023, an estimated $52.7M increase.
  • Erste Asset Management's biggest Q3 2023 reduction was Marriott International, cutting an estimated $51.7M.
  • Erste Asset Management fully exited Viasat in Q3 2023, selling an estimated $18M.
  • Erste Asset Management's ten largest holdings make up 22% of its $5.81B portfolio in Q3 2023.
  • Erste Asset Management opened 28 new positions and closed 52 in Q3 2023.
  • Erste Asset Management's portfolio value rose 2.4% quarter-over-quarter to $5.81B.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.